Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4. This appears to be a minor administrative update to the study record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section with New Jersey as a study site (New Brunswick, New Jersey).SummaryDifference0.2%

- Check58 days agoChange DetectedPubMed publications section wording updated to indicate that publications are auto-filled from PubMed, replacing the previous description. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check66 days agoChange DetectedDeleted the general operating status notice about a lapse in government funding that could affect updates; this does not change trial data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedThe newer screenshot shows added results sections (e.g., adverse events, response and survival metrics) and expanded study plan/eligibility criteria for the trial.SummaryDifference0.4%

- Check109 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.